123 related articles for article (PubMed ID: 2507135)
1. Alterations in polyamine metabolism during continuous intravenous infusion of alpha-difluoromethylornithine showing correlation of thrombocytopenia with alpha-difluoromethylornithine plasma levels.
Ajani JA; Ota DM; Grossie VB; Levin B; Nishioka K
Cancer Res; 1989 Oct; 49(20):5761-5. PubMed ID: 2507135
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravenous alpha-difluoromethylornithine on the polyamine levels of normal tissue and a transplantable fibrosarcoma.
Grossie VB; Ota DM; Ajani JA; Nishioka K
Cancer Res; 1987 Apr; 47(7):1836-40. PubMed ID: 3102050
[TBL] [Abstract][Full Text] [Related]
3. Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trial.
Pendyala L; Creaven PJ; Porter CW
Cancer Epidemiol Biomarkers Prev; 1993; 2(3):235-41. PubMed ID: 8318876
[TBL] [Abstract][Full Text] [Related]
4. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.
O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A
Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756
[TBL] [Abstract][Full Text] [Related]
5. Relationship between heat sensitivity and polyamine levels after treatment with alpha-difluoromethylornithine (DFMO).
Mivechi NF; Dewey WC; Feuerstein BG; Deen DF; Marton LJ
Radiat Res; 1986 Dec; 108(3):269-81. PubMed ID: 3099327
[TBL] [Abstract][Full Text] [Related]
6. Polyamine contents in rectal and buccal mucosae in humans treated with oral difluoromethylornithine.
Boyle JO; Meyskens FL; Garewal HS; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1992; 1(2):131-5. PubMed ID: 1306095
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.
Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706
[TBL] [Abstract][Full Text] [Related]
8. Reduction of difluoromethylornithine-induced thrombocytopenia in rats with ornithine while maintaining antitumor activity.
Grossie VB; Ota DM; Ajani JA; Chang TH; Patenia D; Nishioka K
Cancer Res; 1989 Aug; 49(15):4159-62. PubMed ID: 2501023
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
[TBL] [Abstract][Full Text] [Related]
10. Effects of alpha-difluoromethylornithine-induced polyamine depletion on the radiosensitivity of a human colon carcinoma cell line.
Arundel CM; Nishioka K; Tofilon PJ
Radiat Res; 1988 Jun; 114(3):634-40. PubMed ID: 3131831
[TBL] [Abstract][Full Text] [Related]
11. Red blood cell polyamine levels and host toxicity during continuous alpha-difluoromethylornithine infusion.
Ota DM; Grossie VB; Ajani JA; Stephens LC; Nishioka K
Int J Cancer; 1986 Aug; 38(2):245-9. PubMed ID: 3089944
[TBL] [Abstract][Full Text] [Related]
12. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
[TBL] [Abstract][Full Text] [Related]
13. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
Sunkara PS; Rosenberger AL
Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of mouse colon tumors with difluoromethylornithine during and after carcinogen treatment.
Tempero MA; Nishioka K; Knott K; Zetterman RK
Cancer Res; 1989 Nov; 49(21):5793-7. PubMed ID: 2507137
[TBL] [Abstract][Full Text] [Related]
15. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
[TBL] [Abstract][Full Text] [Related]
16. Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamine.
Pfaller MA; Riley J; Gerarden T
J Med Vet Mycol; 1988 Apr; 26(2):119-26. PubMed ID: 3138402
[TBL] [Abstract][Full Text] [Related]
17. Alterations in bone marrow and blood mononuclear cell polyamine and methylglyoxal bis(guanylhydrazone) levels: phase I evaluation of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) treatment of human hematological malignancies.
Maddox AM; Freireich EJ; Keating MJ; Haddox MK
Cancer Res; 1988 Mar; 48(5):1367-73. PubMed ID: 3124958
[TBL] [Abstract][Full Text] [Related]
18. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.
Carbone PP; Douglas JA; Larson PO; Verma AK; Blair IA; Pomplun M; Tutsch KD
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):907-12. PubMed ID: 9796636
[TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibition of polyamine synthesis and growth by difluoromethylornithine plus methylthioadenosine in methylthioadenosine phosphorylase-deficient murine lymphoma cells.
Yamanaka H; Kubota M; Carson DA
Cancer Res; 1987 Apr; 47(7):1771-4. PubMed ID: 3102048
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition by polyamine biosynthesis inhibitor DFMO of the growth of transplanted human colon cancer in nude mice].
Wang M
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):335-7. PubMed ID: 1782843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
